BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 15878294)

  • 1. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S
    Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell lines: an overview.
    De Vries GH; Boullerne AI
    Neurochem Res; 2010 Dec; 35(12):1978-2000. PubMed ID: 21127972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.
    Acosta S; Lavarino C; Paris R; Garcia I; de Torres C; Rodríguez E; Beleta H; Mora J
    BMC Dev Biol; 2009 Feb; 9():12. PubMed ID: 19216736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
    Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
    Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma GOTO cells are hypersensitive to disruption of lipid rafts.
    Tomioka R; Minami N; Kushida A; Horibe S; Izumi I; Kato A; Fukushima K; Ideo H; Yamashita K; Hirose S; Saito Y
    Biochem Biophys Res Commun; 2009 Nov; 389(1):122-7. PubMed ID: 19706290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
    Rogers DA; Schor NF
    Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.
    Zhang X; Hamada J; Nishimoto A; Takahashi Y; Murai T; Tada M; Moriuchi T
    J Cell Mol Med; 2007; 11(2):299-306. PubMed ID: 17488478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N; Balmas Bourloud K; Brognara CB
    Exp Cell Res; 2000 Nov; 260(2):396-403. PubMed ID: 11035936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human neuroblastoma GOTO cells express CD44 and localize it into lipid rafts upon differentiation into Schwannian cells.
    Hasegawa G; Minami N; Kushida A; Inuyama H; Koga M; Wakabayashi K; Saito Y
    Cell Biol Int; 2005 Mar; 29(3):193-202. PubMed ID: 15878294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
    Combaret V; Coll JL; Favrot MC
    Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
    Liu S; Tian Y; Chlenski A; Yang Q; Salwen HR; Cohn SL
    Cancer Lett; 2005 Oct; 228(1-2):125-31. PubMed ID: 15935552
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.